184 related articles for article (PubMed ID: 27890808)
1. Use of physiologically based kinetic modeling-facilitated reverse dosimetry of in vitro toxicity data for prediction of in vivo developmental toxicity of tebuconazole in rats.
Li H; Zhang M; Vervoort J; Rietjens IM; van Ravenzwaay B; Louisse J
Toxicol Lett; 2017 Jan; 266():85-93. PubMed ID: 27890808
[TBL] [Abstract][Full Text] [Related]
2. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
[TBL] [Abstract][Full Text] [Related]
3. Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.
Zhang M; van Ravenzwaay B; Fabian E; Rietjens IMCM; Louisse J
Arch Toxicol; 2018 Mar; 92(3):1075-1088. PubMed ID: 29234833
[TBL] [Abstract][Full Text] [Related]
4. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
[TBL] [Abstract][Full Text] [Related]
5. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
6. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
[TBL] [Abstract][Full Text] [Related]
7. Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data.
Louisse J; Beekmann K; Rietjens IM
Chem Res Toxicol; 2017 Jan; 30(1):114-125. PubMed ID: 27768849
[TBL] [Abstract][Full Text] [Related]
8. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
[TBL] [Abstract][Full Text] [Related]
9. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.
Chen L; Ning J; Louisse J; Wesseling S; Rietjens IMCM
Food Chem Toxicol; 2018 Jun; 116(Pt B):216-226. PubMed ID: 29634986
[TBL] [Abstract][Full Text] [Related]
10. Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation.
Louisse J; Verwei M; Woutersen RA; Blaauboer BJ; Rietjens IM
Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):11-27. PubMed ID: 22114915
[TBL] [Abstract][Full Text] [Related]
11. The in vivo developmental toxicity of diethylstilbestrol (DES) in rat evaluated by an alternative testing strategy.
Adam AHB; Zhang M; de Haan LHJ; van Ravenzwaay B; Louisse J; Rietjens IMCM
Arch Toxicol; 2019 Jul; 93(7):2021-2033. PubMed ID: 31119342
[TBL] [Abstract][Full Text] [Related]
12. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
[TBL] [Abstract][Full Text] [Related]
13. Extended evaluation on the ES-D3 cell differentiation assay combined with the BeWo transport model, to predict relative developmental toxicity of triazole compounds.
Li H; Flick B; Rietjens IM; Louisse J; Schneider S; van Ravenzwaay B
Arch Toxicol; 2016 May; 90(5):1225-37. PubMed ID: 26047666
[TBL] [Abstract][Full Text] [Related]
14. Predicting the in vivo developmental toxicity of benzo[a]pyrene (BaP) in rats by an in vitro-in silico approach.
Wang D; Rietdijk MH; Kamelia L; Boogaard PJ; Rietjens IMCM
Arch Toxicol; 2021 Oct; 95(10):3323-3340. PubMed ID: 34432120
[TBL] [Abstract][Full Text] [Related]
15. Physicologically Based Toxicokinetic Models of Tebuconazole and Application in Human Risk Assessment.
Jónsdóttir SÓ; Reffstrup TK; Petersen A; Nielsen E
Chem Res Toxicol; 2016 May; 29(5):715-34. PubMed ID: 26977527
[TBL] [Abstract][Full Text] [Related]
16. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
17. Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach.
Fragki S; Hoogenveen R; van Oostrom C; Schwillens P; Piersma AH; Zeilmaker MJ
Toxicology; 2022 Jan; 465():153060. PubMed ID: 34871708
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.
Zhao S; Wesseling S; Spenkelink B; Rietjens IMCM
Arch Toxicol; 2021 May; 95(5):1573-1593. PubMed ID: 33715020
[TBL] [Abstract][Full Text] [Related]
19. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
[TBL] [Abstract][Full Text] [Related]
20. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
